Terry Opgenorth

Dr. Opgenorth joined KromaTiD’s Board in 2010. Most recently, he served as Vice President and Executive Director of LAUNCHPAD at CSU Ventures, CEO of Vidasym, a company developing drugs for chronic kidney disease, and CSO/Co-Founder of VetDC, a veterinary oncology company. Prior to that Terry spent 20yrs with Abbott Laboratories (now AbbVie), most recently as Vice President of Metabolic Disease Research, Antiviral (HCV) Research and Target-Lead Discovery Research in Global Pharmaceutical R & D. He is a Director for VetDC, UNeMed, Forecast Orthopedics, and Sparta Healthcare Acquisition Corp.. Dr. Opgenorth holds a B.A. in Liberal Arts (biology major) from Calvin University and M.S. and Ph.D. degrees in Physiology from University of Illinois-Urbana.